Ybañez, Criza A.

HRN: 22-64-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
CEFUROXIME 1.5GM (VIAL)
04/13/2024
04/20/2024
IV
1.5g
Q8h
UTI
Waiting Final Action 
04/15/2024
MEBENDAZOLE 500MG (TAB)
04/15/2024
04/15/2024
PO
Single Dose
Now
Ascariasis
Waiting Final Action 
02/28/2025
AMPICILLIN 1GM (VIAL)
03/01/2025
03/04/2025
IVT
2g
Q6
Prophylaxis
Waiting Final Action 
03/01/2025
CEFUROXIME 1.5GM (VIAL)
03/01/2025
03/02/2025
IVT
1.5g
PTOR
Prophylaxis
Waiting Final Action 
03/01/2025
CEFUROXIME 500MG (TAB)
03/01/2025
03/08/2025
PO
500 Mg Tab
BID
PPROM, SP LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: